“Clinical Trial Management: Monitoring Progress, Sites and Safety; New Paradigms for Efficiency”, in 5th Annual Clinical Research Management Workshop at the Yale Center for Clinical Investigation, New Haven, CT, 2012.
, “Clinical trial design in chronic migraine: Lessons learned from the NINDS CRC chronic migraine treatment trial (CMTT) (poster)”, in International Headache Society, Berlin, Germany, 2011.
, “Clinical trial design in chronic migraine: Lessons learned from the NINDS CRC chronic migraine treatment trial (CMTT)”, presented at the 2011, Washington, D.C., 2011.
, “Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers”, in HIVR4P (HIV Research for Prevention), Cape Town, South Africa, 2014.
, “Clinical and Genomic Analysis of Metastatic Disease Progression in a Background of Biochemical Recurrence”, in 2012 ASTRO - American Society for Radiation Oncology, Boston, MA, 2012.
, “Clinic vs. Reading Center Evaluation of Dense Retinal Hemorrhage at Baseline in the SCORE Branch Retinal Vein Occlusion (BRVO) Study”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
, “CITR: Long Term Data Update of Islet Transplantation”, in Rachmiel Levine Diabetes and Obesity Symposium, Pasadena, CA, 2012.
, “Ciliary Neurotrophic Factor (CNTF) Phase I Trial for Human Retinal Degenerations”, in The 35th Annual Meeting for the Society for Neuroscience, Washington, DC, 2005.
, “Characterization of Reticular Drusen and Association with Age Macular Degeneration through Multiple Imaging Modalities”, in Association for Research in Vision and Ophthalmology - ARVO, Ft. Lauderdale, FL, 2012.
, “Characterization of Baseline Heart Rate Variability (HRV) within the “Brain Injury and Mechanisms of Action of Hyperbaric Oxygen (HBO2) for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI)” Study (BIMA)”, in Military Health System Research Symposium, 2014.
, “Characterization of Baseline EEG Abnormalities in the Brain Injury and Mechanisms of Action of Hyperbaric Oxygen (HBO2) for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) Study (BIMA)”, in Undersea and Hyperbaric Medical Society Annual Scientific Meeting; AAN Sports Concussion Conference; Military Health System Research Symposium, 2014.
, “Characteristics of CD34-Enriched Products Processed at Multiple Centers Using the CliniMACS System - BMT CTN 0303 (Abstract).”, in 16th Annual ISCT (International Society for Cellular Therapy) Meeting, Philadelphia, 2010.
, “Change in Area of Intraretinal Macular Hemorrhages in Aflibercept- and Bevacizumab-treated Central Retinal and Hemiretinal Vein Occlusions: A SCORE2 Subanalysis”, in 43rd Annual Macula Society, San Diego, CA, 2020.
, “Challenges of Use and Compliance With Effective Contraceptives Among Female Participants in Preventive HIV Vaccine Trials: The Kenyan Experience”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
, “Challenges Experienced By the Clinical Team During The Conduct of HIV Vaccine Clinical Trials in Kenya”, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
, “Challenges and Best Practices for Recruitment and Retention During the COVID Pandemic.”, in Society for Clinical Trials (SCT) Annual Conference, Virtual, 2021.
, “Cellular and Humoral Immunogenicity of ADMVA, a Clade C/B MVA-Based HIV-1 Candidate Vaccine, in Healthy Volunteers”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
, “Brightness, Contrast, and Color Balance of Digital vs. Film Retinal Images in the Age-Related Eye Disease Study 2”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2008.
, “BOLD-100-001 (TRIO039): A phase Ib Dose-escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Gastrointestinal Solid Tumors”, in ASCO Annual Meeting, 2021.
, “Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA’s Clinical Trials Network (CTN)”, in College on Problems of Drug Dependence Meeting, San Diego, CA, 2013.
, “BK virus is not a significant cause of graft loss in HIV+ kidney recipients (oral presentation)”, presented at the 2011, Philadelphia, PA, 2011.
, “BK and JC Polyomavirus (PyV) in HIV-1 Infected Kidney Transplant Recipients (KTR)”, in Interscience Conference on Antimicrobial Agents and Chemotherapy - ICAAC 2013, Denver, CO, 2013.
, “The best single time point measurement correlations with AUC for cyclosporine and tacrolimus in HIV-1 infected liver and kidney transplant recipients (poster session)”, in World Congress of Nephrology, Vancouver, Canada, 2011.
, “Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss”, in 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG), Berlin, Germany, 2005.
, “Baseline Nutritional Characteristics of the Age-Related Eye Disease Study 2 (AREDS2) Cohort”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2009.
,